SEC Form 4Coverage since Aug 3, 2026
$CAMP insider trading
Over the last 12 months, Camp4 Therapeutics insiders reported 4 buys totaling $59K and no sales across SEC Form 4 filings.
- Bought · 12m
- $59K 4 events
- Sold · 12m
- — 0 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $CAMP · 12Mvia TradingView
Top insiders · 12m
Young Richard A—1× · $27K
Mandel-Brehm JoshChief Executive Officer1× · $11K
Maricich YuriChief Medical Officer1× · $11K
Gold KellyChief Financial Officer1× · $11K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Mandel-Brehm JoshChief Executive Officer · O·D | ▲ Buy | 6,551 | $1.65 | $11K | +2.4% | — |
| Aug 3, 2026 | Young Richard AD | ▲ Buy | 16,378 | $1.65 | $27K | +9.6% | — |
| Aug 3, 2026 | Maricich YuriChief Medical Officer · O | ▲ Buy | 6,551 | $1.65 | $11K | +108.1% | — |
| Aug 3, 2026 | Gold KellyChief Financial Officer · O | ▲ Buy | 6,551 | $1.65 | $11K | +9.7% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CAMP feed.